Background: Breast cancer remains an important medical challenge, despite sustained global efforts at its prevention and control. Various immunological factors are expressed in the serum during breast tumourigenesis, and can be of value in the surveillance of the disease. These serum bio-markers include pro-inflammatory cytokines since breast cancer is associated with chronic inflammation. In our locality with different racial/ethnic variations from Caucasian as well as environmental factors, there is scanty information on the value of these serum factors in screening and surveillance of breast cancer-hence the need for this study. Methodology: A total of 68 females (mean age = 48.7 ± 8.7 yrs) with clinically and pathologically confirmed breast cancer were recruited by self selection; representing breast cancer patients group. Due to small sample size they were further grouped into advanced stage breast cancer cases (N = 40) and early stage breast cancer cases (N = 28). Controls consisted of two groups: A-Patient control group (N = 21) comprised females with benign breast tumour (15 cases with fibroadenoma and 6 cases with fibrocystic disease) and group B-apparently healthy age/sex matched control group (N = 21). Pre-treatment samples were collected after which all patients underwent standard treatment modalities (neoadjuvant or adjuvant chemotherapy, radiotherapy, chemoradiation, and/or surgery; depending on the stage of presentation and thereafter post treatment samples were collected after 3 and 6 months respectively. Serum from the patients and controls were assayed immunoenzymatically for TNF-α and IL-1. Results: The results showed that at 6 months post-treatment stage, the mean values of IL-1 differed significantly (P > 0.05) when advanced stage breast cancer were compared with early stage and apparently healthy control groups respectively. Likewise at 6 months post-treatment stage, the TNF-α mean values differed significantly (P > 0.05) How to cite this paper: Felix, C.E., Ehigiator, I. No significant differences in mean values were recorded across disease and treatment groups in both IL-1 and TNF-α at pre-treatment and 3 months post-treatment stages. Majority of the breast cancer patients studied were married (91%) and had children, of low income, never smoke cigarette, diagnosed at age above 46 years and presented at advanced stages of the disease.
Introduction
The incidence of breast cancer is increasing worldwide [1] [2] [3] even among countries that used to have low prevalence with some genetic variables as a result of environmental and other factors. It is the most frequently diagnosed cancer in women and the leading cause of cancer related death [2] [3] . Thus, there is the need to develop immunological based techniques with diagnostic and/or prognostic potentials.
African countries present with low prevalence, more aggressive, increased mortality, earlier age at presentation (35 -45 years) and different pattern of gene expression [4] [5] [6] . Various risk factors accounting for difference in prevalence rates have been identified and include genetic and epigenetic factors largely due to breast cancer gene type 1 (BRCA 1) and breast cancer gene type 2 (BRCA 2) mutations [7] [8], history of breast cancer, ethnicity, reproduction factors [9] [10] [11] and menstrual history. Breast cancer is a heterogeneous disease with a large number of prognostic variables.
The tumour microenvironment is an important aspect of cancer biology that contributes to tumour initiation, tumour progression and responses to therapy.
The composition and characteristics of the tumour microenvironment vary widely and are important in determining the anti-tumour immune response [12] . Most cancers arise in association with chronic inflammation and contain inflammatory infiltrates [13] . Immune cells have broad impact on tumour initiation, growth, and progression and many of these effects are mediated by some cytokines. Among these cytokines, the pro-tumourigenic function of tumour Tumour necrosis factor (TNF-α) mediates a broad range of biological activities and encompasses beneficial effects for the host in inflammation and in protective immune responses against a variety of infectious pathogens [19] .
Pro-inflammatory cytokine TNF-α is required for de novo carcinogenesis and is important to early stages of tumour promotion [20] , acts as a mediator for IL-1
and IL-8 production and induces NF-B signaling pathway activation in stem-like phenotype [21] . In response to inflammation and infection, TNF-α elicits its pro-inflammatory signals by initially binding to receptors, TNFR1
(p55) and TNFR2 (p75) on the cell surface [22] via three distinct signaling pathways leading to the activation of caspases and the activation of AP-1 and NFkB transcription factors which lead to a range of cellular responses, including cell death, survival, differentiation, proliferation and migration. The tumour-promoting functions of TNF-α is associated to its ability to induce proangiogenic functions, to promote the expression of matrix metalloproteinases (MMP) and endothelial adhesion molecules, and to cause DNA damage via reactive oxygen, the overall effect of which is promotion of tumor-related processes [23] .
Interleukin 1 (IL-1); another inflammatory cytokine produced by activated macrophages with effects similar to that of TNF-α and also helps to activate T cells [22] [24] . There are two forms of this prototypic pro-inflammatory cytokine; IL-1α and IL-1β and in most studies [25] [26]; their biological activities are indistinguishable and play an important role in immune regulation and inflammatory processes by inducing expression of many effector proteins, e.g. cytokines/chemokines, nitric oxide synthetase and matrix metalloproteinases (MMPs) [27] . IL-1 is involved in breast cancer progression and it is a potential inducer of IL-8 production by breast cancer cells in vitro [21] . Excessive and/or dysregulated activity of these mediators is associated with tissue destruction and therefore the synthesis, secretion and biological activity of IL-1 cytokines have been identified as therapeutic targets for common inflammatory disorders such as rheumatoid arthritis (RA) and periodontitis.
The outcome of breast cancer is usually determined by multiple factors. Serum tumor necrosis factor alpha (TNF-α) concentration has been found to be increased in the circulation of patients with malignancy. Preoperative evaluation of serum TNF-α concentration has been found to be a valuable parameter for reflecting the severity of staging for invasive breast cancer [28] and correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer [29] .
Discrete roles of IL-6, IL-1 and TNF-α in tumour promotion and cell transformation have been demonstrated [15] [30] and found to be of good clinical importance. In breast cancer, the IL-1 levels is significantly higher in invasive car- It is therefore necessary to examine some of these pro-inflammatory cytokines as they affect women from this environment. In apparently healthy sex/age-matched control, one blood sample was taken from each participant. The samples were allowed to clot, centrifuged at 5000 rpm for 5 minutes, serum separated and stored at −20˚C until analyzed.
Materials and Methods

Subjects and Sampling
Assay Methods
Abcam's TNF-α in vitro Simple StepTM ELISA method were adopted for TNF-α (kit sourced from abcamR, UK, Cat #ab181421) and IL-1a (kit sourced from abcamR, UK, Cat #ab178008) estimations. The simple
Step ELISA employs a labeled capture and detector antibody which immunocaptures the sample analyte in solution. This entire complex (capture antibody /detector antibody) is in turn immobilized in the well by immunoaffinity via the anti-tag antibody. Sample or standard are added to wells, followed by the antibody mix. After incubation, the wells are washed to remove unbound material; the TMB substrate is then added.
The reaction is stopped by addition of stop Solution which stops the colour development and completes any colour change from blue to yellow. Signal is generated proportionally to the amount of bound analyte and the intensity is measured at 450 nm.
A standard curve was constructed for each method using the respective standard and use for the determination of unknown respective serum sample concentrations.
Statistical Analysis
Data were analyzed using statistical package for Social Sciences (SPSS) software.
Statistical significance was set at p < 0.05. Dunn's multiple comparison tests and
Kruskall-Wallis analysis of variance were applied for measuring the differences between disease and treatment groups. GraphPad prism version 6.0 (by GraphPad, USA) was used for the graphs.
Results
Majority of the breast cancer patients studied were married (91%) and had children, of low income, never smoke cigarette, diagnosed at age above 46 years and presented at advanced stages of the disease. Results also showed that 78% of the cases did not have any history of cancer in their families. Also, 63% of the cases had body mass index values suggestive of obesity (>30 kg/m 2 ). Table 1 shows some demographic parameters of the breast cancer patients studied.
The mean values and statistical comparison of TNF-α and IL-1 in disease groups (breast cancer cases and benign breast tumour) were presented in Table   2 & Table 3 were recorded across disease and treatment groups in both IL-1 and TNF-α at pre-treatment and 3 months post-treatment stages.
No statistical significant difference in TNF-α and IL-1was observed when the breast cancer groups were condensed. Similar results were recorded instead.
Discussion
Despite the improvement in health facilities; majority of the patients in this study were of low income level and presented at advanced stages of the disease when little or no benefit can be derived from any form of therapy. Out of the 68 breast cancer cases studied, 28 patients presented at early stage (stages 1 and 2), while 40 patients presented at advanced stage of the disease (stages 3 and 4).
This could be attributed to poverty, lack of free screening centers and ignorance;
giving room for incorporeal interpretation for such health problems. This is in- The prime limitation encountered was that of follow up for the repeat sampling after various forms of treatment because some patients resorted to unorthodox and spiritual healingand some traveled overseas or died. Some patients therefore, were lost to follow-up and that affected the comparison after six months pos-treatment.
